Precision medicine for metastatic breast cancer—limitations and solutions

被引：0
|
作者：
Monica Arnedos
Cecile Vicier
Sherene Loi
Celine Lefebvre
Stefan Michiels
Herve Bonnefoi
Fabrice Andre
机构：
[1] Gustave Roussy and Université Paris Sud,Department of Medical Oncology
[2] INSERM Unit U981,Department of Biostatistics and Epidemiology
[3] Gustave Roussy and Université Paris Sud,Division of Research and Cancer Medicine
[4] Gustave Roussy and Université Paris Sud,Department of Medical Oncology and INSERM U916
[5] Peter MacCallum Cancer Centre,undefined
[6] University of Melbourne,undefined
[7] Institut Bergonié,undefined
来源：
Nature Reviews Clinical Oncology | 2015年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent research data defining the genomic landscape of breast cancer have reinforced the notion that this disease is driven by genomic alterationsSo far very few gene drivers validated in breast cancer have been identified, including ESR1, ERBB 2, PIK3CA and ATK1Identification of drivers, characterization of resistant clones, identification of DNA repair defects and mechanisms of immune suppression are potential uses of genomics to personalize medicineThe development of precision medicine for the treatment of breast cancer has several major challenges that include low frequency of targetable molecular alterations, feasibility of high-throughput technologies and availability of targeted therapy
引用
收藏
页码：693 / 704
页数：11
相关论文
共 50 条
  • [41] Precision Medicine and Clinical Trials in Advanced and Metastatic Oral Cancer
    Joshi, Asim
    Ghosh, Abantika
    Ramachandran, Venkataramanan
    Kuriakose, Moni
    Prabhash, Kumar
    Kumar, Prashant
    JOURNAL OF MAXILLOFACIAL & ORAL SURGERY, 2024, 23 (04): : 772 - 782
  • [42] Clinical target sequencing for precision medicine of breast cancer
    Tsuchida, Junko
    Rothman, Jami
    McDonald, Kerry-Ann
    Nagahashi, Masayuki
    Takabe, Kazuaki
    Wakai, Toshifumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (02) : 131 - 140
  • [43] Molecular Breast Cancer Imaging in the Era of Precision Medicine
    Muzahir, Saima
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (06) : 1512 - 1519
  • [44] Empowering precision medicine: regenerative AI in breast cancer
    Bhattacharya, Sudip
    Saleem, Sheikh Mohd
    Singh, Alok
    Singh, Sukhpreet
    Tripathi, Shailesh
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Nuclear medicine contribution to precision surgery in breast cancer
    Olmos, R. A. Valdes
    Vidal-Sicart, S.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 343 - 351
  • [46] Clinical target sequencing for precision medicine of breast cancer
    Junko Tsuchida
    Jami Rothman
    Kerry-Ann McDonald
    Masayuki Nagahashi
    Kazuaki Takabe
    Toshifumi Wakai
    International Journal of Clinical Oncology, 2019, 24 : 131 - 140
  • [47] Targeting Stemness: Implications for Precision Medicine in Breast Cancer
    Liang, Zhi-Mei
    Chen, Yang
    Luo, Man-Li
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 147 - 169
  • [48] Moving beyond endocrine therapy for luminal metastatic breast cancer in the precision medicine era: looking for new targets
    Morganti, Stefania
    Curigliano, Giuseppe
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2020, 5 (01): : 7 - 22
  • [49] Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine
    Silverstein, Allison
    Sood, Rachita
    Costas-Chavarri, Ainhoa
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2016, 2016
  • [50] Clinical Utility of Precision Medicine in Early Breast Cancer: What Is the Optimal Framework to Develop Precision Medicine?
    Nozawa, Kazuki
    Hattori, Masaya
    Yoshimura, Akiyo
    Iwata, Hiroji
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1962 - +
12345